409A valuation AI Medical Service AOT asset valuation Biotech firms Biotechgate Biotechgate Digital Partnering brain activity measuring breast cancer Cells clinical trial database Cold Ablation Robotguided Laser Osteotome cranio-maxillofacial surgery Cyrill Bätscher early digestive track cancer detection Ferring Pharmaceutical filming Fujieda Ayumi Funding future of life sciences Gergely Ivanyi German Biotech German Life Sciences GTAI Health Made in Germany Heartseed Inc. HelloPartnering in-licensing opportunities JPM San Francisco Kiyoshi Hasegawa life science database Lily MedTech Inc. medical image analysis NeU Corporation patrik frei product valuation RESI Rhine-Main-Neckar biotech SARS CoV 2 Shiho Azuma Tomohiro Tada valuation Valuation Experts XB-01 Yone Production Co Ltd
May 2020: Founded by a woman engineer caring for women’s health, the 3D whole breast ultrasound diagnostic imaging system demonstrates not only leading-edge technology but also considerate features for examinees.
Venture Valuation (VV) interviewed, Mrs. Shiho AZUMA, Founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
As an industry-university joint venture of Hitachi High Technology Division and Tohoku University Institute of Development, Aging and Cancer, NeU is introducing a unique brain activity measuring device for individual use.
Venture Valuation (VV) interviewed Kiyoshi Hasegawa, CEO of NeU.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Founded by an accomplished gastroenterologist, AI Medical Service is determined to contribute to the detection of early cancer in the digestive tract by leveraging a CNN deep learning algorithm.
Venture Valuation (VV) interviewed Tomohiro Tada, Founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Founded by four experts in laser physics, medical image analysis, and cranio-maxillofacial surgery, AOT is reinventing the bone surgery field with laser osteotomy technology: CARLO® (Cold Ablation Robotguided Laser Osteotome).
Applying intelligently glycemic control and a systematic route through the BBB (blood-brain barrier) to effectively reach neurons. Venture Valuation (VV) interviewed the CEO, Mariko Tosu, PhD (more…)
ITO has developed, since its inception in 1916, high-end professional use therapeutic modalities as well as innovative personal use devices.
Venture Valuation (VV) interviewed the COO, Mayuko Ito, great-granddaughter of the founder Kenji Ito.
Inspired by co-founder Lea von Bidder’s concept, the Ava bracelet is
becoming an indispensable device for women to monitor their own biological rhythms.
Venture Valuation (VV) interviewed Vicky Kummer, Global Brand Manager.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Invented by Prof. Hiroshi Kobayashi, Department of Mechanical Engineering, Tokyo University of Science, the Muscle Suit® is becoming an indispensable device for the elderly care services
as well as many other heavy lifting tasks. Venture Valuation (VV) interviewed Takashi Furukawa, CEO.
Would you like to be notified about new reports and other valuable content published by Venture Valuation?
Current transfusion medicine entirely relies on donated
blood. Megakaryon will change the transfusion practices by supplying
safe and cost-saving platelets produced in vitro. Mass production in
Japan is expected to begin in 2020. Venture Valuation (VV) interviewed Genjiro Miwa, CEO and Founder.
Leveraging its proprietary technology of culturing highly purified dendritic cells (DCs), tella is developing, as its first immunotherapeutic product, a DC-based vaccine in combination with WT1 (Wilms’ tumor gene 1) antigen for inoperable pancreatic cancer. Venture Valuation (VV) interviewed Dr. Yuichiro Yazaki, President and CEO.